Dose adjustments of Elexacaftor/Tezacaftor/Ivacaftor in response to mental health side effects in adults with cystic fibrosis.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2022-11-01 | PMID 35585012
Spoletini G, Gillgrass L, Pollard K and 5 more
